Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK

AIMS: The purpose of this study was to evaluate the cost-effectiveness of iron repletion using intravenous (i.v.) ferric carboxymaltose (FCM) in chronic heart failure (CHF) patients with iron deficiency with or without anaemia. Cost-effectiveness was studied from the perspective of the National Heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutzwiller, Florian S., Schwenkglenks, Matthias, Blank, Patricia R., Braunhofer, Peter G., Mori, Claudio, Szucs, Thomas D., Ponikowski, Piotr, Anker, Stefan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Pharmacoeconomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380546/
https://www.ncbi.nlm.nih.gov/pubmed/22689292
http://dx.doi.org/10.1093/eurjhf/hfs083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380546/
https://www.ncbi.nlm.nih.gov/pubmed/22689292
http://dx.doi.org/10.1093/eurjhf/hfs083

Ejemplares similares